Mark Lee, Global Head for Personalized Healthcare, Product Development at Genentech/Roche
Mark Lee, MD, PhD
SVP PD Head PHC 2.0
Mark Lee is a medical oncologist and the Global Head for Personalized Healthcare, Product Development at Genentech/Roche.
Prior to joining Genentech, Mark was a member of the founding leadership team and Head of Clinical Development and Medical Affairs at GRAIL, where he built one of the largest clinical research programs in genomic medicine aimed at early cancer detection. Mark’s previous roles include Lead for Oncology Clinical Sciences at Google[x] Life Sciences, Chief Medical Officer at Boreal Genomics, and Vice President of Oncology Development at Genomic Health, where he led the successful development and validation of the Oncotype DX Colon and Prostate Cancer Assays. His prior work also includes design and conduct of clinical trials for tissue-based and molecular imaging biomarker discovery at Genentech.
Mark holds a PhD in Biological Chemistry and Molecular Pharmacology from Harvard, and a MD from Stanford University, where he completed his internal medicine training and medical oncology fellowship.